Robert Weinstein, Chief Financial Officer at Synaptogenix, Inc. (SNPX), sold 27,000 shares at $1.17 ($32K) on 2022-12-16, disclosed to the SEC on 2022-12-20.
Scheduled sale ($32k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| XSPA | SELL | 2022-04-22 | $48K | — | Filing → |
| XSPA | SELL | 2022-01-21 | $70K | — | Filing → |
| XSPA | SELL | 2021-10-22 | $90K | — | Filing → |